Ergon Capital, a mid-market private equity firm, has acquired a majority stake in the Millbo-BioNaturals Group. This deal represents a strategic play within the high-growth natural food ingredients sector, aimed at transforming a family-owned technical leader into a global institutional platform. The strategic rationale for the investment centers on leveraging Ergon’s international network and financial resources to accelerate the group's geographic expansion and to pursue a consolidation strategy in a highly fragmented market. The structure ensures strong management continuity, with the CEO and former controlling shareholder, Alessandro Boggiani, reinvesting in the business to drive the next phase of development. This transaction follows the buyer's existing sector expertise, notably its previous investment in the bakery segment.

MILLBO BIONATURALS GROUP, which reported an EBITDA margin of LOGIN in 2019, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level around LOGIN higher than the average currently observed in the AgriFood sector (10.1x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.